Notice of Intent to Sole Source - Final.pdf

Notice of Intent to Sole Source

HT941025N0105

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS

NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division – West (HCD-W), San Diego, intends to negotiate and award a firm fixed price contract modification under HT941023P0215 for Chemistry Analyzers in accordance with Federal Acquisition Regulation (FAR) 13.501(a) Sole Source acquisitions and FAR 13.106- 1(b)(1)(i), only one source being available to meet the Government’s needs, to:

Roche Diagnostics Corporation 9115 Hague RD Indianapolis, Indiana 46256-1025

The North American Industry Classification System (NAICS) code for this requirement is 334516 - Analytical Laboratory Instrument Manufacturing; the business size standard is 1,000 Employees. The Product Service Code (PSC) is 6330 - Chemical Analysis Instruments.

The requirement is for a contract for the lease of two (2) Chemistry analyzers, annual off-site key operator training for each analyzer, purchase of reagents, third party quality controls (Bio-Rad), maintenance service, and consumables for Naval Health Clinic (NHCH). One (1) clinical chemistry/immunoassay analyzer shall be for Branch Health Clinic (BHC) Makalapa, and one (1) clinical chemistry analyzer shall be for BHC Kaneohe Bay. The contracted analyzer for Makalapa shall be a single platform configuration capable of performing general chemistry, immunoassay, and screening for electrolytes, diabetes, hepatic diseases, thyroid diseases, cardiac diseases, renal diseases, and infectious diseases, as defined below. The contracted analyzer for BHC Kaneohe Bay shall be capable of performing general chemistry, and screening for electrolytes, hepatic diseases, renal diseases, and cardiac diseases. The contracted analyzers for each clinic shall be capable of performing the tests listed below at the yearly indicated test volume.

The contracted analyzers for BHC Makalapa and BHC Kaneohe Bay shall have the same test methodology to ensure accuracy of results between clinics. The contractor shall be capable of 24-hour response time. The contractor shall be available for telephone troubleshooting consultation 24 hours a day, 7 days a week, 365 days per year, except on Federal holidays. The contract shall include operator training. The contract shall include water purifiers connected to the analyzers, its' maintenance service, and all consumables.

BHC Makalapa Requirements:

The contracted analyzer shall be an integrated general chemistry and immunoassay analyzer providing a single footprint. The contracted analyzer shall be capable of completing a minimum of 375 tests per hour.

Due to space constraints, the contracted analyzer shall fit within the following dimensions: 70 inches (H) x 98 inches (W) x 32 inches (D). The contracted analyzer shall perform all the analytes at the annual estimated test volume as indicated below.

2025 ANNUAL ESTIMATED TEST VOLUME (REPORTABLE) - BHC MAKALAPA

TEST QTY TEST QTY TEST QTY

ALBUMIN 9515 CREATININE 13347 POTASSIUM 8531

ALKP 9024 CREATINE KINASE 867 SODIUM 8494

ALT 8998 GGT 1140 T3, FREE 464

AST 10518 GLUCOSE 10149 T4, FREE 2273

BICARBONATE 8468 BETA HCG 889 TOTAL PROTEIN 8927

BILIRUBIN, DIRECT 1079 HDL 7580 TRIGLYCERIDES 7554

BILIRUBIN, TOTAL 9065 HBA1C 9915 TSH 7804

CALCIUM 8512 LDL 7342 UREA/BUN 10923

CHLORIDE 8487 MAGNESIUM 1103 URIC ACID 573

CHOLESTEROL, TOTAL 7601 PHOSPHORUS 869 URINE CREATININE Added to Creatinine

BHC Kaneohe Bay Requirements:

The contracted general chemistry analyzer shall be capable of completing a minimum of 375 tests per hour. The contracted analyzer shall fit within the following dimensions: 70 inches (H) x 58 inches (W) x 32 inches (D). The contracted analyzer shall perform all the analytes at the annual estimated test volume as indicated below.

2025 ANNUAL ESTIMATED TEST VOLUME (REPORTABLE) - BHC KANEOHE BAY

TEST QTY TEST QTY TEST QTY

ALBUMIN 4655 CHLORIDE 4353 PHOSPHORUS 611

ALKP 4489 CHOLESTEROL, TOTAL 3665 POTASSIUM 4370

ALT 4384 CREATININE 4796 SODIUM 4355

AST 4680 GGT 425 TOTAL PROTEIN 4382

BICARBONATE 4372 GLUCOSE 5629 TRIGLYCERIDES 3653

BILIRUBIN, DIRECT 796 HDL 3653 UREA/BUN 4773

BILIRUBIN, TOTAL 4524 LDL 3642 URIC ACID 367

CALCIUM 4368

Base Period: 01 October 2023 - 30 September 2024 Option Period 1: 01 October 2024 - 30 September 2025 Option Period 2: 01 October 2025 - 30 September 2026 Option Period 3: 01 October 2026 - 30 September 2027 Option Period 4: 01 October 2027 - 30 September 2028

This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the required supplies to NHCH.

Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point.

All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order.

If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to April L. Delmendo at april.l.delmendo.civ@health.mil. The closing date for challenges is no later than 8:00am Pacific Time, 30 June 2025.

mailto:april.l.delmendo.civ@health.mil